Literature DB >> 2308166

Deletion-tolerance and trans-splicing of the bacteriophage T4 td intron. Analysis of the P6-L6a region.

J L Galloway Salvo1, T Coetzee, M Belfort.   

Abstract

Non-directed mutagenesis and phylogenetic comparison suggest that certain elements of the bacteriophage T4 td group Ia intron are dispensable to self-splicing. The L6-P6a-L6a region was identified as a potential non-essential element, and was removed by sequential deletions extending from the L6a loop toward the P6 pairing. Assays for splicing indicate that as long as the P6 pairing is maintained, the 1016 nucleotide td intron can be reduced to less than 250 nucleotides while maintaining function in vivo and in vitro. The P6 pairing appears to be essential for splicing while P6a is not. In addition, a spontaneous pseudorevertant of a splicing-defective deletion was isolated and shown to result from a single nucleotide change in the predicted L6a loop. This genetic suppressor mimics the ability of Mg2+ to reverse the phenotype of the deletion, suggesting that function is restored by structural stabilization of P6. The tolerance of this region to deletion prompted us to split the ribozyme core in L6a, to generate precursors that might function in trans. Indeed, the two half-molecules do associate to form a bimolecular complex that yields accurately ligated exons both in vitro and in vivo. The biological implications of these results, as well as the usefulness of trans-splicing for generating unprocessed precursors in vitro are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308166     DOI: 10.1016/0022-2836(90)90264-m

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  27 in total

1.  Influence of specific mutations on the thermal stability of the td group I intron in vitro and on its splicing efficiency in vivo: a comparative study.

Authors:  P Brion; R Schroeder; F Michel; E Westhof
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

2.  Design of highly specific cytotoxins by using trans-splicing ribozymes.

Authors:  B G Ayre; U Köhler; H M Goodman; J Haseloff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Optimization of trans-splicing ribozyme efficiency and specificity by in vivo genetic selection.

Authors:  Brian G Ayre; Uwe Köhler; Robert Turgeon; Jim Haseloff
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

4.  RNA chaperone StpA loosens interactions of the tertiary structure in the td group I intron in vivo.

Authors:  Christina Waldsich; Rupert Grossberger; Renée Schroeder
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

Review 5.  Mechanisms of StpA-mediated RNA remodeling.

Authors:  Martina Doetsch; Thomas Gstrein; Renée Schroeder; Boris Fürtig
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

6.  RNA chaperone activity of protein components of human Ro RNPs.

Authors:  Aurélia Belisova; Katharina Semrad; Oliver Mayer; Grazia Kocian; Elisabeth Waigmann; Renée Schroeder; Günter Steiner
Journal:  RNA       Date:  2005-05-31       Impact factor: 4.942

7.  A region of group I introns that contains universally conserved residues but is not essential for self-splicing.

Authors:  K P Williams; D N Fujimoto; T Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Synthesis of circular RNA in bacteria and yeast using RNA cyclase ribozymes derived from a group I intron of phage T4.

Authors:  E Ford; M Ares
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Escherichia coli protein analogs StpA and H-NS: regulatory loops, similar and disparate effects on nucleic acid dynamics.

Authors:  A Zhang; S Rimsky; M E Reaban; H Buc; M Belfort
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

10.  Lead cleavage sites in the core structure of group I intron-RNA.

Authors:  B Streicher; U von Ahsen; R Schroeder
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.